Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
NRP Find Missing Seniors
Chippawa Park Undergoing Rejuvenation
Mayor Aims to Teach Kids Politics
Man Charged After Accidental Shooting
NRP Looking for Vandalism Suspects
Pelham Weighs Hydro Line Burial Options
Niagara Region Concludes Toronto Meetings
Gates Calling for MRI Wait Time Reduction